Vijay Pande Resigns from Leadership Role at a16z Bio+ Health

June 11, 2025 - 14:18

Vijay Pande, a prominent figure in the biotechnology and health investment sector, has announced his departure from his role as a founding partner at a16z Bio+ Health. Since its inception in 2014, a16z Bio+ Health has made significant strides in the industry, successfully raising four funds totaling nearly $3 billion. Among these, the most notable is the $1.5 billion fund that closed in 2022, reflecting the growing interest and investment in the life sciences sector.

Pande's leadership has been instrumental in shaping the firm’s strategy and fostering innovation within the biotechnology landscape. His expertise and vision have helped the firm identify and support groundbreaking companies that are transforming healthcare. As he steps down, the future direction of a16z Bio+ Health remains a point of interest for investors and industry observers alike. The firm is expected to continue its focus on investing in companies that leverage cutting-edge science and technology to address pressing health challenges.